Therapeutic FGF19 promotes HDL biogenesis and transhepatic cholesterol efflux to prevent atherosclerosis
出版年份 2019 全文链接
标题
Therapeutic FGF19 promotes HDL biogenesis and transhepatic cholesterol efflux to prevent atherosclerosis
作者
关键词
-
出版物
JOURNAL OF LIPID RESEARCH
Volume 60, Issue 3, Pages 550-565
出版商
American Society for Biochemistry & Molecular Biology (ASBMB)
发表日期
2019-01-25
DOI
10.1194/jlr.m089961
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Retrospective on Cholesterol Homeostasis: The Central Role of Scap
- (2018) Michael S. Brown et al. Annual Review of Biochemistry
- Accelerated Atherogenicity in Tangier Disease
- (2018) Jun Muratsu et al. Journal of Atherosclerosis and Thrombosis
- ABCG5 and ABCG8: more than a defense against xenosterols
- (2018) Shailendra B. Patel et al. JOURNAL OF LIPID RESEARCH
- NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
- (2018) Stephen A Harrison et al. LANCET
- Liver X receptors in lipid signalling and membrane homeostasis
- (2018) Bo Wang et al. Nature Reviews Endocrinology
- Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2017) Mohsen Naghavi et al. LANCET
- Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease
- (2017) NEW ENGLAND JOURNAL OF MEDICINE
- Non-cell-autonomous activation of IL-6/STAT3 signaling mediates FGF19-driven hepatocarcinogenesis
- (2017) Mei Zhou et al. Nature Communications
- Beneficial and Adverse Effects of an LXR Agonist on Human Lipid and Lipoprotein Metabolism and Circulating Neutrophils
- (2016) Todd G. Kirchgessner et al. Cell Metabolism
- A Century of Cholesterol and Coronaries: From Plaques to Genes to Statins
- (2015) Joseph L. Goldstein et al. CELL
- Bile Acids as Hormones: The FXR-FGF15/19 Pathway
- (2015) Steven A. Kliewer et al. DIGESTIVE DISEASES
- Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23
- (2015) Chiara Degirolamo et al. NATURE REVIEWS DRUG DISCOVERY
- LXRs link metabolism to inflammation through Abca1-dependent regulation of membrane composition and TLR signaling
- (2015) Ayaka Ito et al. eLife
- Macrophage-Independent Regulation of Reverse Cholesterol Transport by Liver X Receptors
- (2014) Sarah R. Breevoort et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Separating Tumorigenicity from Bile Acid Regulatory Activity for Endocrine Hormone FGF19
- (2014) M. Zhou et al. CANCER RESEARCH
- A nontumorigenic variant of FGF19 treats cholestatic liver diseases
- (2014) J. Luo et al. Science Translational Medicine
- Shaping macrophages function and innate immunity by bile acids: Mechanisms and implication in cholestatic liver diseases
- (2014) Yvon Calmus et al. Clinics and Research in Hepatology and Gastroenterology
- Serum Levels of Fibroblast Growth Factor 19 Are Inversely Associated with Coronary Artery Disease in Chinese Individuals
- (2013) Yaping Hao et al. PLoS One
- Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: A randomized controlled trial
- (2012) Thuy-Anh Le et al. HEPATOLOGY
- The ABCG5 ABCG8 Sterol Transporter Opposes the Development of Fatty Liver Disease and Loss of Glycemic Control Independently of Phytosterol Accumulation
- (2012) Kai Su et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Treating Diabetes and Obesity with an FGF21-Mimetic Antibody Activating the Klotho/FGFR1c Receptor Complex
- (2012) I. N. Foltz et al. Science Translational Medicine
- FGF15/19 Regulates Hepatic Glucose Metabolism by Inhibiting the CREB-PGC-1α Pathway
- (2011) Matthew J. Potthoff et al. Cell Metabolism
- Nascent HDL formation in hepatocytes and role of ABCA1, ABCG1, and SR-BI
- (2011) Ailing Ji et al. JOURNAL OF LIPID RESEARCH
- FGF19 as a Postprandial, Insulin-Independent Activator of Hepatic Protein and Glycogen Synthesis
- (2011) S. Kir et al. SCIENCE
- Amelioration of Type 2 Diabetes by Antibody-Mediated Activation of Fibroblast Growth Factor Receptor 1
- (2011) A.-L. Wu et al. Science Translational Medicine
- Targeted Deletion of Hepatocyte ABCA1 Leads to Very Low Density Lipoprotein Triglyceride Overproduction and Low Density Lipoprotein Hypercatabolism
- (2010) Soonkyu Chung et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Biological, clinical and population relevance of 95 loci for blood lipids
- (2010) Tanya M. Teslovich et al. NATURE
- Tissue-Specific Roles of ABCA1 Influence Susceptibility to Atherosclerosis
- (2009) Liam R. Brunham et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Fibroblast Growth Factor-19, a Novel Factor That Inhibits Hepatic Fatty Acid Synthesis
- (2009) Sushant Bhatnagar et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A proprotein convertase subtilisin/kexin type 9 neutralizing antibody reduces serum cholesterol in mice and nonhuman primates
- (2009) J. C. Y. Chan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- LXR Regulates Cholesterol Uptake Through Idol-Dependent Ubiquitination of the LDL Receptor
- (2009) Noam Zelcer et al. SCIENCE
- Fifty years of advances in bile acid synthesis and metabolism
- (2008) David W. Russell JOURNAL OF LIPID RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started